Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition

BackgroundIncreased collagen deposition provides physical and biochemical signals to support tumor growth and invasion during breast cancer development. Therefore, inhibition of collagen synthesis and deposition has been considered a strategy to suppress breast cancer progression. Collagen prolyl-4-hydroxylase α subunit 2 (P4HA2), an enzyme hydroxylating proline residues in -X-Pro-Gly- sequences, is a potential therapeutic target for the disorders associated with increased collagen deposition. However, expression and function of P4HA2 in breast cancer progression are not well investigated.MethodsGene co-expression analysis was performed in the published microarray datasets to identify potential regulators of collagen I, III, and IV in human breast cancer tissue. Expression of P4HA2 was silenced by shRNAs, and its activity was inhibited by 1, 4-DPCA, a prolyl-4-hydroxylase inhibitor. Three-dimensional culture assay was used to analyze roles of P4HA2 in regulating malignant phenotypes of breast cancer cells. Reduced deposition of collagen I and IV was detected by Western blotting and immunofluorescence. Control and P4HA2-silenced breast cancer cells were injected into fat pad and tail vein of SCID mice to examine effect of P4HA2 on tumor growth and lung metastasis.ResultsUsing gene co-expression analysis, we showed that P4HA2 was associated with expression of Col1A1, Col3A1, and Col4A1 during breast cancer development and progression. P4HA2 mRNA levels were significantly upregulated in breast cancer compared to normal mammary tissue. Increased mRNA levels of P4HA2 correlated with poor clinical outcome in breast cancer patients, which is independent of estrogen receptor status. Silencing P4HA2 expression or treatment with the P4HA inhibitor significantly inhibited cell proliferation and suppressed aggressive phenotypes of breast cancer cells in 3D culture, accompanied by reduced deposition of collagen I and IV. We also found that knockdown of P4HA2 inhibited mammary tumor growth and metastasis to lungs in xenograft models.ConclusionThese results suggest the critical role of P4HA2 in breast cancer progression and identify P4HA2 as a potential therapeutic target and biomarker for breast cancer progression.

[1]  Edi Brogi,et al.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.

[2]  Gordon B Mills,et al.  Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. , 2012, Cancer cell.

[3]  Robert P. Jenkins,et al.  Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts , 2013, Nature Cell Biology.

[4]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[5]  M. Tang,et al.  A tale of two collagen receptors, integrin β1 and discoidin domain receptor 1, in epithelial cell differentiation. , 2012, American journal of physiology. Cell physiology.

[6]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[7]  G. Xiong,et al.  RORα suppresses breast tumor invasion by inducing SEMA3F expression. , 2012, Cancer research.

[8]  A. Pozzi,et al.  Integrin α1β1 Mediates a Unique Collagen-dependent Proliferation Pathway In Vivo , 1998, The Journal of cell biology.

[9]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[10]  K. Rubin,et al.  Pericytes as collagen-producing cells in excessive dermal scarring. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[11]  Allison Jones,et al.  cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells , 2003, Oncogene.

[12]  K. Kadler,et al.  Recombinant expression systems for the production of collagen. , 2000, Biochemical Society transactions.

[13]  R. Mattingly,et al.  Three-Dimensional Overlay Culture Models of Human Breast Cancer Reveal a Critical Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibitors , 2010, Journal of Pharmacology and Experimental Therapeutics.

[14]  K. J. Grande-Allen,et al.  Age-related changes in collagen synthesis and turnover in porcine heart valves. , 2007, The Journal of heart valve disease.

[15]  Timothy J. Mitchison,et al.  A chemical method for fast and sensitive detection of DNA synthesis in vivo , 2008, Proceedings of the National Academy of Sciences.

[16]  J. Myllyharju,et al.  Characterization of the human and mouse genes for the α subunit of type II prolyl 4‐hydroxylase , 2001 .

[17]  C. Ries,et al.  Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab , 2009, Oncogene.

[18]  D. Fletcher,et al.  Patterned Collagen Fibers Orient Branching Mammary Epithelium through Distinct Signaling Modules , 2013, Current Biology.

[19]  E. Petricoin,et al.  Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. , 2005, The Journal of clinical investigation.

[20]  G. Bell,et al.  Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy , 2012, Proceedings of the National Academy of Sciences.

[21]  M. Bissell,et al.  Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress. , 2006, Advances in cancer research.

[22]  J. Myllyharju.  Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[23]  M J Bissell,et al.  Involvement of extracellular matrix constituents in breast cancer. , 1995, Seminars in cancer biology.

[24]  K. Kivirikko,et al.  Cloning of the Human Prolyl 4-Hydroxylase α Subunit Isoform α(II) and Characterization of the Type II Enzyme Tetramer , 1997, The Journal of Biological Chemistry.

[25]  Z. Szallasi,et al.  An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.

[26]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[27]  J. Myllyharju,et al.  Extracellular matrix genes as hypoxia-inducible targets , 2009, Cell and Tissue Research.

[28]  J. Segall,et al.  Intravital imaging of cell movement in tumours , 2003, Nature Reviews Cancer.

[29]  S. Dangi‐Garimella,et al.  Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion* , 2011, The Journal of Biological Chemistry.

[30]  N. Pedemonte,et al.  Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling. , 2011, American journal of physiology. Cell physiology.

[31]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[32]  J. Muschler,et al.  Cell-matrix interactions in mammary gland development and breast cancer. , 2010, Cold Spring Harbor perspectives in biology.

[33]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[34]  G. Semenza,et al.  Collagen prolyl hydroxylases are essential for breast cancer metastasis. , 2013, Cancer research.

[35]  Jie Zhou,et al.  Autophagy in cancer associated fibroblasts promotes tumor cell survival , 2010, Cell cycle.

[36]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Sleijfer,et al.  Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response , 2008, Clinical Cancer Research.

[38]  Paolo P. Provenzano,et al.  Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.

[39]  Krzysztof Fujarewicz,et al.  Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. , 2005, Cancer research.

[40]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[41]  Ying Liang,et al.  Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. , 2011, Journal of proteome research.

[42]  R. Xu,et al.  Gene transcriptional networks integrate microenvironmental signals in human breast cancer. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[43]  C. Larabell,et al.  Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Gang Bai,et al.  Profiling and comparative analysis of glycoproteins in Hs578BST and Hs578T and investigation of prolyl 4-Hydroxylase alpha polypeptide II expression and influence in breast cancer cells , 2012, Biochemistry (Moscow).

[45]  R. Stephenson,et al.  Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones. , 2001, The Biochemical journal.

[46]  C. Rueden,et al.  Bmc Medicine Collagen Density Promotes Mammary Tumor Initiation and Progression , 2022 .

[47]  D. Sheer,et al.  Assignment of the gene coding for the alpha-subunit of prolyl 4-hydroxylase to human chromosome region 10q21.3-23.1. , 1989, American journal of human genetics.

[48]  K. Kivirikko,et al.  Cloning of the human prolyl 4-hydroxylase alpha subunit isoform alpha(II) and characterization of the type II enzyme tetramer. The alpha(I) and alpha(II) subunits do not form a mixed alpha(I)alpha(II)beta2 tetramer. , 1997, The Journal of biological chemistry.

[49]  Kevin W. Eliceiri,et al.  The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis , 2013, Nature Cell Biology.

[50]  T. Aigner,et al.  Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels. , 2006, The American journal of pathology.

[51]  Denis Wirtz,et al.  Hypoxia-inducible Factor 1 (HIF-1) Promotes Extracellular Matrix Remodeling under Hypoxic Conditions by Inducing P4HA1, P4HA2, and PLOD2 Expression in Fibroblasts* , 2013, The Journal of Biological Chemistry.

[52]  Mina J. Bissell,et al.  Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function , 2009, The Journal of cell biology.

[53]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[54]  Ronald T. Raines,et al.  Prolyl 4-hydroxylase , 2010, Critical reviews in biochemistry and molecular biology.

[55]  K. Kivirikko,et al.  Identification and Characterization of a Third Human, Rat, and Mouse Collagen Prolyl 4-Hydroxylase Isoenzyme* , 2003, Journal of Biological Chemistry.

[56]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.